Tirzepatide for weight loss in people with obesity
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial looks at whether a medicine called tirzepatide (given as an injection) helps people with obesity lose weight in real life. Researchers will also see how people use the medicine, which may help doctors find better ways to treat obesity.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You need to have a BMI of 30 or more, or a BMI of 27 to 29.9 with a condition related to your weight (like high blood pressure or high cholesterol).
- You should not have had previous treatment for obesity, such as weight-loss medication, weight-loss procedures, or weight-loss surgery.
- You cannot have diabetes.
- You cannot be pregnant or become pregnant during the trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a medicine called tirzepatide to see if it helps people with overweight or obesity lose weight, whether or not they also have type 2 diabetes. Tirzepatide is given as an injection and works on hormones that control appetite.
This trial tests if tirzepatide is more effective than standard obesity treatments for adults who have a BMI between 30 and 35 and one weight-related health condition, but do not have diabetes. The goal is to help you lose weight.
This study tests a medication called tirzepatide (a daily injection) to help people who haven't lost enough weight after weight-loss surgery. If you fit the criteria, the medication may help you lose more weight healthily.
This Phase 2 study tests whether tirzepatide can improve how your body handles fat (especially in people with overweight or obesity) and reduce fat-related “lipotoxicity.” It may help with body fat function and related health markers, but you must meet specific health and medication rules.
This study tests a weekly injection called tirzepatide to help people with obesity lose weight. It will be done at Hospital de Clínicas in Paraguay and lasts about 12 months.
This study tests a medication called tirzepatide (a once-weekly injection) to help teenagers with obesity and related health conditions lose weight. It aims to see if the drug is safe and effective for this age group.
Hear when a new Obesity (Disorder) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.